Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants

R P Verma1, K M McCulloch, L Worrell

  • 1Department of Pediatrics, University of Illinois, Chicago 60612, USA.

Insights

Persistent vitamin A deficiency in preterm infants is linked to a higher risk of severe bronchopulmonary dysplasia. This deficiency also correlates with delayed enteral feeding and lower vitamin A intake in these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Nutritional Science
  • Pediatric Pulmonology

Background:

  • Preterm infants frequently exhibit low serum vitamin A levels.
  • Prolonged vitamin A deficiency may contribute to bronchopulmonary dysplasia development.

Purpose of the Study:

  • To investigate the association between persistent vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants.

Main Methods:

  • Retrospective analysis of 22 infants with birthweight <= 1250g requiring mechanical ventilation.
  • Serum vitamin A concentrations measured serially from enteral feeding onset.
  • Comparison of infants with low (< or = 11 mcg/dL) versus higher (> 11 mcg/dL) serum vitamin A levels after 10 days of age.

Main Results:

  • Severe bronchopulmonary dysplasia incidence was significantly higher in the low vitamin A group (11/13) compared to the higher vitamin A group (1/9).
  • The low vitamin A group experienced more pulmonary air leaks, ventilator days, and antibiotic treatments.
  • Infants with low vitamin A were older at enteral feeding onset and had lower daily vitamin A intake.

Conclusions:

  • Persistent vitamin A deficiency in very low birthweight infants is associated with increased severe bronchopulmonary dysplasia.
  • Vitamin A deficiency correlates with delayed enteral feeding and reduced vitamin A intake.
  • Findings support earlier reports linking vitamin A deficiency to adverse respiratory outcomes in preterm infants.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...